simlerid 100 mg
lek pharmaceuticals d.d. - slovenia - sitagliptinum - compr. film. - 100mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
sitagliptin dr. reddy's 100 mg
betapharm arzneimittel gmbh - germania - sitagliptinum - compr. film. - 100mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
jansitin 100 mg
laboratorios liconsa s.a. - spania - sitagliptinum - compr. film. - 100mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
jansitin 25 mg
laboratorios liconsa s.a. - spania - sitagliptinum - compr. film. - 25mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
jansitin 50 mg
laboratorios liconsa s.a. - spania - sitagliptinum - compr. film. - 50mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
sitagliptin grindeks 100 mg
as grindeks. - letonia - sitagliptinum - compr. film. - 100mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
sitagliptin grindeks 25 mg
as grindeks. - letonia - sitagliptinum - compr. film. - 25mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
sitagliptin grindeks 50 mg
as grindeks. - letonia - sitagliptinum - compr. film. - 50mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
sitagliptin/metformin teva 50 mg/1000 mg
laboratorios liconsa s.a. - spania - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.